<qa>  What is the recommended phase II dose?Cohorts of 3-6 patients except for 1 patient at starting dose receive escalating doses of OGX-011 until the maximum tolerated dose MTD is determined. The MTD is defined as the dose at which at least 2 of 3 or 2 of 6 patients experience dose-limiting toxicity. The recommended phase II dose is the dose preceding the MTD. 